iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post‐hoc analysis of the LixiLan JP‐L trial

INTRODUCTION: Treatments for type 2 diabetes targeting baseline glucose levels but not postprandial glucose can result in normalized fasting blood glucose but suboptimal overall glycemic control (high glycated hemoglobin): residual hyperglycemia. In Japanese patients with type 2 diabetes the predomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabe, Daisuke, Iizuka, Katsumi, Baxter, Mike, Watanabe, Daisuke, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565419/
https://www.ncbi.nlm.nih.gov/pubmed/33945227
http://dx.doi.org/10.1111/jdi.13563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565419/
https://www.ncbi.nlm.nih.gov/pubmed/33945227
http://dx.doi.org/10.1111/jdi.13563

Ejemplares similares